Results 131 to 140 of about 56,937 (260)

Emergence of Fosfomycin Resistance Among ESBL‐Producing Escherichia coli in Abadan, Southwestern Iran

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aim Escherichia coli is a key pathogen responsible for various infections, such as urinary tract infections, gastroenteritis, and wound infections. The increasing occurrence of antimicrobial resistance, particularly in extended‐spectrum β‐lactamase (ESBL)‐producing strains, poses a significant global health threat.
Nabi Jomehzadeh, Ali Fakari
wiley   +1 more source

Unveiling carbapenem resistance: mechanism and therapeutic strategies

This review provides an overview of the carbapenem resistance, its underlying causing microbes, its mechanism of transmission, risk factors, and its treatment options and challenges. Carbapenem resistance in Gram-negative organisms such as E. coli and K.
H., Fiza S., U., Mounashree, R., Thanushree D., A., Sanjana   +3 more
core   +1 more source

Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa: A Narrative Review of Preclinical and Clinical Evidence

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Phage therapy shows promising efficacy against MDR, XDR, and PDR Pseudomonas aeruginosa infections across different models and administration routes. Evidence highlights reduced mortality, bacterial clearance, and synergy with antibiotics, while emphasizing the need for standardized protocols and advanced delivery systems to support clinical ...
Gustavo Aparecido da Cunha, Raine Piva Amaral, Ana Luisa Cauvila dos Santos, Bárbara Rafaela Ferreira Aio, Maria Fernanda Romboli Durante, Luiz Cosme Cotta Malaquias, Gabriel Magno de Freitas Almeida, Luiz Felipe Leomil Coelho   +7 more
wiley   +1 more source

Profile of outer membrane proteins of carbapenem-resistant Gram-negative bacilli in Ghana

BMC Research Notes
Objective Carbapenem resistance is a major global health threat, but insights on its molecular determinants are scanty in sub-Saharan Africa, the predominant global antimicrobial resistance hotspot.
Francis S. Codjoe, Fleischer C. N. Kotey, Eric S. Donkor   +2 more
doaj   +1 more source

When First‐Line Therapies Fail: Surgical Site Infections and the Declining Antimicrobial Utility in a Resource‐Limited Nation

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
In Belize, a 7‐year nationwide study reveals a sharp rise in antimicrobial resistance in surgical infections. ESBL‐producing bacteria more than doubled to > 45%, with critical treatment gaps and geographic hotspots identified. Sentinel pan‐drug‐resistant cases and a correlation between antibiotic use and resistance underscore the urgent need for ...
Innocent E. Nwachukwu, Cary W. Rivera, Vivian M. Reyes, Diomar Salazar, Lydia Harris‐Thurton, Danladi C. Husaini   +5 more
wiley   +1 more source

Impact of The COVID-19 Pandemic on Carbapenem and Colistin Resistance of Gram-Negative Bacteria Isolated from Laboratory-Confirmed Healthcare-Associated Infections in Intensive Care Units [PDF]

Introduction: The coronavirus disease 2019 (COVID-19) pandemic may have influenced antibiotic usage patterns. In particular, increased empirical use of broad-spectrum agents may have affected bacterial resistance profiles.
İlker Yıldırım, Melike Demir, Melike Nur Özçelik, İlknur Erdem   +3 more
core   +1 more source

Wastewater‐Based Assessment of Antimicrobial Resistance and Bacterial Communities in Urban and Rural Areas in the Province of Trento (Italy)

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Wastewater from urban and rural areas was analyzed to investigate antimicrobial‐resistant bacteria and resistance genes. ESBL‐Escherichia coli and genes coding for clinically relevant resistances, namely, those to macrolides, carbapenems, and vancomycin, were higher in urban than in rural areas.
Maya Petricciuolo, Agnese Carnevali, Alessia Torboli, Mattia Postinghel, Alessia Guasticchi, Paola Foladori, Maria Cadonna, Ermanno Federici   +7 more
wiley   +1 more source

Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt

Infection and Drug Resistance, 2019
Rasha El-Mahdy,1 Ghada El-Kannishy2 1Department of Medical Microbiology And Immunology, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 2Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, EgyptCorrespondence ...
El-Mahdy R, El-Kannishy G
doaj  

Bedside Risk Scoring for Carbapenem-Resistant Gram-Negative Bacterial Infections in Patients with Hematological Malignancies

Infectious Disease Reports
Background/Objectives: This study aimed to create a ‘carbapenem resistance score’ with the risk factors of carbapenem-resistant Gram-negative bacterial infections (GNBIs) in patients with hematological malignancies.
Sare Merve Başağa, Ayşegül Ulu Kılıç, Zeynep Ture, Gökmen Zararsız, Serra İlayda Yerlitaş   +4 more
doaj   +1 more source

Associations between Carbapenem Use, Carbapenem-Resistant Pseudomonas aeruginosa, and Carbapenem-Resistant Acinetobacter baumannii [PDF]

Infection Control & Hospital Epidemiology, 2013
Anucha, Apisarnthanarak, Sumana, Jitpokasem, Linda M, Mundy   +2 more
openaire   +2 more sources